코로나19 판데믹 사태에서 대한진단검사의학회의 초기 대응 현황
Initial Response of the Korean Society for Laboratory Medicine to the COVID-19 Pandemic
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
코로나바이러스감염증-19 (코로나19)는 2019년 말에 중국에서 시작되어 전세계로 전파된 대유행을 발생시켰다. 코로나19의 원인 병원체는 SARS 바이러스와 계통학적으로 유사한 신종바이러스로 밝혀 졌기에 SARS-CoV-2로 명명되었다. 코로나19의 증상은 비특이적이고, 환자뿐만 아니라 무증상 감염자에 의한 전파가 가능하기 때문에 환자의 호흡기 검체에서 바이러스를 검출하는 것이 진단에 필수적이다. 따라서 코로나19 사태 초기에는 신속하고 정확한 진 단을 통하여 감염자를 감별하고 적절한 격리 및 치료 등의 대처가 질병 확산 예방에 중요했다. 본 논문에서는 코로나19에 대해 간략 한 문헌 고찰과 함께 대한진단검사의학회가 유관 학회, 산업계, 정 부 등의 유기적인 협력을 바탕으로 정확한 분자진단검사법을 조기에 전국적으로 정착시킨 과정과 경험을 공유하고자 하였다.
Abstract
The coronavirus disease (COVID-19) pandemic originated in Wuhan, China, at the end of 2019. The cause of COVID-19 is severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel virus phylogenetically similar to the SARS virus. The symptoms of COVID-19 are non-specific, and transmission of SARS-CoV-2 can occur through contact with infected persons as well as asymptomatic carriers. Therefore, it is vital to diagnose COVID-19 by detecting the virus in respiratory samples. In the early period of the COVID-19 outbreak, infected people were identified through a rapid and accurate diagnosis. Accordingly, an initial response, such as appropriate quarantine and treatment, was critical in preventing the spread of the disease. This report briefly reviews the literature on COVID-19 and shares the experience of the Korean Society for Laboratory Medicine for the early establishment of molecular diagnostic testing with the cooperation of stakeholders.
참고문헌 (17)
- 홍소희, "Lessons Learned from SARS-CoV and MERS-CoV: Preparation for SARS-CoV-2 induced COVID-19", Journal of Bacteriology and Virology, 50(2), pp.76~96 (2020), 대한미생물학회
- Dhama K, "Coronavirus disease 2019-COVID-19", Clin Microbiol Rev, 33, pp.e00028-20~ (2020)
- Wu A, "Genome composition and divergence of the novel coronavirus(2019-nCoV)originating in China", Cell Host Microbe, 27, pp.325~328 (2020)
- Pascarella G, "COVID-19 diagnosis and management : a comprehensive review", J Intern Med, 288, pp.192~206 (2020)
- Zhou M, "Coronavirus disease 2019(COVID-19) : a clinical update", Front Med, 14, pp.126~135 (2020)
- 허중연, "코로나바이러스감염병-19 초기 유행의 임상 역학적 특성", 대한내과학회지, 95(2), pp.67~73 (2020), 대한내과학회[DOI]
- 박수은, "Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19)", Clinical and Experimental Pediatrics, 63(4), pp.119~124 (2020), 대한소아청소년과학회
- Ge H, "The epidemiology and clinical information about COVID-19", Eur J Clin Microbiol Infect Dis, 39, pp.1011~1019 (2020)
- Li Q, "Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia", N Engl J Med, 382, pp.1199~1207 (2020)
- Wu JT, "Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China : a modelling study", Lancet, 395, pp.689~697 (2020)
- Riou J, "Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus(2019-nCoV), December 2019 to January 2020", Euro Surveill, 25, pp.2000058~ (2020)
- Byambasuren O, "Estimating the extent of asymptomatic COVID-19 and its potential for community transmission : systematic review and meta-analysis", medRxiv, 5, pp.223~234 (2020)
- Koh WC, "What do we know about SARS-CoV-2 transmission? A systematic review and meta-analysis of the secondary attack rate and associated risk factors", PLoS One, 15, pp.e0240205~ (2020)
- "Coronavirus disease (COVID-19): Serology, antibodies and immunity" (2020)[URL]
- "Antibody Testing Interim Guidelines" (2021)[URL]
- "Antibody (serology) testing for COVID-19: Information for patients and consumers" (2020)[URL]
- "IDSA guidelines on the diagnosis of COVID-19: Serologic testing" (2020)[URL]